FDA Approves Eli Lilly's New Obesity Drug, Sparking Competition with Novo Nordisk

The FDA has given the green light to Eli Lilly's latest obesity medication, positioning it in direct rivalry with Novo Nordisk's recently launched Wegovy pill.